Literature DB >> 11402081

Psychotherapy of adults with comorbid attention-deficit/hyperactivity disorder and psychoactive substance use disorder.

R B Aviram1, M Rhum, F R Levin.   

Abstract

Psychotherapy for comorbid attention-deficit/ hyperactivity disorder (ADHD) and psychoactive substance use disorder (PSUD) is described. The authors suggest that relapse prevention is an appropriate initial treatment because it is well suited to manage both substance abuse and comorbid symptomatology such as impulsivity, distractibility, and avoidance associated with ADHD. Clinical vignettes describe typical interactions between patients and their therapists, highlighting opportunities for therapists to focus on overlapping symptoms. ADHD is one of the most common comorbid diagnoses with PSUD, and it is important that efficacious psychotherapies be developed to complement psychopharmacological approaches. Clinicians should consider psychotherapy as part of a multimodal treatment approach that includes medication and perhaps family therapy. Additional contributions from clinicians who have experience conducting psychotherapy with this population are needed in order to develop effective treatments.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11402081      PMCID: PMC3330647     

Source DB:  PubMed          Journal:  J Psychother Pract Res        ISSN: 1055-050X


  13 in total

1.  Practical guidelines for the treatment of substance abusers with adult attention-deficit hyperactivity disorder.

Authors:  F R Levin; S M Evans; H D Kleber
Journal:  Psychiatr Serv       Date:  1999-08       Impact factor: 3.084

2.  Psychotherapy of adults with attention-deficit disorder.

Authors:  J Bemporad; M Zambenedetti
Journal:  J Psychother Pract Res       Date:  1996

3.  Does ADHD affect the course of substance abuse? Findings from a sample of adults with and without ADHD.

Authors:  T E Wilens; J Biederman; E Mick
Journal:  Am J Addict       Date:  1998

4.  Attention deficit hyperactivity disorder (ADHD) is associated with early onset substance use disorders.

Authors:  T E Wilens; J Biederman; E Mick; S V Faraone; T Spencer
Journal:  J Nerv Ment Dis       Date:  1997-08       Impact factor: 2.254

5.  Attention-deficit/hyperactivity disorder and substance use: symptom pattern and drug choice.

Authors:  C Clure; K T Brady; M E Saladin; D Johnson; R Waid; M Rittenbury
Journal:  Am J Drug Alcohol Abuse       Date:  1999-08       Impact factor: 3.829

6.  Attention deficit hyperactivity disorder and treatment outcome in opioid abusers entering treatment.

Authors:  V L King; R K Brooner; M S Kidorf; K B Stoller; A F Mirsky
Journal:  J Nerv Ment Dis       Date:  1999-08       Impact factor: 2.254

7.  History and significance of childhood attention deficit disorder in treatment-seeking cocaine abusers.

Authors:  K M Carroll; B J Rounsaville
Journal:  Compr Psychiatry       Date:  1993 Mar-Apr       Impact factor: 3.735

8.  Unrecognized attention-deficit hyperactivity disorder in adults presenting for outpatient psychotherapy.

Authors:  J J Ratey; M S Greenberg; J R Bemporad; K J Lindem
Journal:  J Child Adolesc Psychopharmacol       Date:  1992       Impact factor: 2.576

9.  Adult outcome of hyperactive boys. Educational achievement, occupational rank, and psychiatric status.

Authors:  S Mannuzza; R G Klein; A Bessler; P Malloy; M LaPadula
Journal:  Arch Gen Psychiatry       Date:  1993-07

10.  Prevalence of adult attention-deficit hyperactivity disorder among cocaine abusers seeking treatment.

Authors:  F R Levin; S M Evans; H D Kleber
Journal:  Drug Alcohol Depend       Date:  1998-09-01       Impact factor: 4.492

View more
  3 in total

1.  International Consensus Statement on Screening, Diagnosis and Treatment of Substance Use Disorder Patients with Comorbid Attention Deficit/Hyperactivity Disorder.

Authors:  Cleo L Crunelle; Wim van den Brink; Franz Moggi; Maija Konstenius; Johan Franck; Frances R Levin; Geurt van de Glind; Zsolt Demetrovics; Corné Coetzee; Mathias Luderer; Arnt Schellekens; Frieda Matthys
Journal:  Eur Addict Res       Date:  2018-03-06       Impact factor: 3.015

Review 2.  Attention deficit hyperactivity disorder (ADHD) and substance use disorders.

Authors:  J J Wilson; F R Levin
Journal:  Curr Psychiatry Rep       Date:  2001-12       Impact factor: 8.081

3.  Randomized Controlled Trial of an Integrated Family-Based Treatment for Adolescents Presenting to Community Mental Health Centers.

Authors:  Ashli J Sheidow; Kristyn Zajac; Jason E Chapman; Michael R McCart; Tess K Drazdowski
Journal:  Community Ment Health J       Date:  2020-10-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.